Leadership in Enhancing Antimicrobial Discovery
Who we are and what we do
The Leadership in Enhancing Antimicrobial Discovery (LEAD) coalition works to develop leadership and build collaboration
to advance science and shape policy for action against
antimicrobial resistance (AMR).
Our unique challenge
The global crisis in human resources and leadership for antimicrobial discovery and development, follows years of under-investment and a fragmented and changing global science and technology landscape.
The LEAD coalition works to build a more coherent and collaborative global antimicrobial discovery and development ecosystem through cooperation, capacity and leadership development drawing experts from AMR science, policy and advocacy from academia, industry, and the public and third sectors.
The LEAD Objectives
- Advance science for antimicrobial discovery
- Shape policy to support sustainable innovation
- Build leadership and capacity in global partners
- Foster collaboration across disciplines and sectors
The LEAD Approach
LEAD addresses the human resource and leadership gap in antimicrobial R&D by:
- Supporting collaboration between health systems and life science R&D strategies
- Encouraging open science and public-led innovation
- Bridging science, policy, and implementation
- Promoting equitable participation beyond traditional partners
